Vaccines alliance signs $5 million advance deal for Merck's Ebola shot
0
DAVOS/LONDON (Reuters) - The Gavi global alliance for vaccines and immunization group signed a $5 million advance purchase commitment on Wednesday to buy a vaccine being developed by Merck to protect against future outbreaks of the deadly Ebola virus.